Member Info for Krustysmegma

I didn't think it was rude ToS1963, just passing comment. I'll take on board your reply though.

It could also be lucrative if their development work is successful. In effect, a win win for SAR if they come up with the goods. Which, for me, means it's potentially a better deal than Sierra.

Potnak: "...has entered into a development and commercialisation licence agreement for SRA737 (the "Licensing Agreement") with a private biopharma company based in the United States (the "Licensee Company")."

So yes, it's a private company, as they say in the RNS.

Potnak: "...Sareum is entitled to receive US$137,500 from the upfront fee payable under the Licensing Agreement, as well as 27.5% of any future payments payable by the Licensee Company (including any Consideration Shares received), under the terms of the Licensing Agreement."

So yes, we would get 27% of the 500k shares.

"Indeed it seems to suggest that some assets have already been disposed of, yet the capital realised was used to “reduce gearing”. Whatever that means."

Are you serious? You can't be invested here (or anywhere for that matter) if you don't understand basic terminology, surely?

This is a fairly typical reaction to SAR news.

Nobody wants to sell in case the SP has further to run.

Nobody wants to buy in case it doesn't hold.

See how it evolves during the day, but a fairly proportionate rise considering the news which is very welcome.

Apols, NAV less 1% is currently c. 72p, not 70p.

Anyone else thinking of taking the cash option? Would be NAV less 1%, so currently around 70p. Slightly more than the 68.8p that will go towards buying HHI shares currently. I suspect the gap will narrow or disappear completely before decision day but worth keeping an eye on?

Crusty, fwiw I've invested in a whole gaggle of turkeys myself (this, DDDD, HAWK, FDI, VOG, CTT, HEIQ, TRP) but fortunately found a couple of diamonds that have kept my head above water. Moral of the story seems to be - don't follow Crusty/Krusty when planning an investment! Best of luck to all invested here & elsewhere. K

#kievsky

Kievski has already claimed the 8.5m (7 Dec) unless there were 2 trades of 8.5m?

Not sure what the driver is for the current re-rate but whatever it is it's very welcome.

Interesting to look back at one of your posts on 30th October StarBright. You speculated about companies in the US being tempted to come in for GSF whilst there is such a huge discount to the NAV. It'll certainly be interesting to see if Nidec add to their holding in the open market, they'll be able to pick up shares much more cheaply than the 112.9p paid for the subscription shares. Really exciting development for shareholders here IMV.

Thanks gixer, I've messaged them. It's not for me as it happens but one of the people I've recommended to take Fruitflow over the years.

Doesn't seem to have improved your stress levels though colbalt. Oh, & Fruitflow's not a blood thinner either fyi.

I know there has been discussion about this on here some time ago so can anyone remind me? What's the view on taking Fruitflow if you're on a statin?

Thanks.

Just watching the Investor Meet Company presentation from GSF. NAV has dropped to 112.9p at period-end due mainly to higher inflation and increased discount rate due to interest rate rises. I think it much less likely now to achieve the hoped-for 8p dividend in the current year. 7.5p yield still represents a good return on 85.3p share price though. Apart from very weak UK pricing, as previously indicated, all other reporting appears positive, particularly in terms of revenue generation from US assets.

Moving to bi-annual dividend payment though, so we probably won't see another payment until Sep/Oct.

Absolutely damofarl, or 13 years as the company has declared it has sight of future secure income. It means trying to find another decent, reliable dividend payer to invest in, in an environment where many are putting up the shutters. Life gets harder & harder every day for income seekers in the London markets. Maybe a white knight will appear to take the assets on, but no-one has come in for VSL or RMII and they've got very similar stories to tell. Let's see.

The other thing that gets me about this, and other similar scenarios, is the large shareholders pushing for liquidation so they can show a quick profit to cover their losses elsewhere. I'm not as pessimistic about the future as many are, so I believe (perhaps naively) things will look much better in 6 - 12 months time. Surely they can ride that out?

It's not the first Trek. In my portfolio alone this is also the fate of VSL and RMII. HDIV is being subsumed within HHI and there are plenty of others that I'm aware of. It makes me sick to my stomach, decent Trusts/companies that are well run, paying a reliable dividend but just can't survive the NAV gap. They're basically being strangled by the UK market at a time when they should be flag-flying leaders of the recovery. It's beyond frustrating, it really is. We need, at the very least, a clear signal from the BoE that interest rates have peaked and are likely to start falling next year, otherwise this carnage will be repeated all over the place.